Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other aches and pains.
CVS says it will stop selling tobacco products at its 7,600 stores by October, becoming the first U.S. drugstore chain to take cigarettes off the shelf.
GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff.
The U.S. manufacturing sector is forecast to grow again next year, with both revenue and investment increasing, an industry report shows.
Stocks followed Friday’s big rally by basically marching in place, but a couple of mergers gave the market a boost, including the completion of the US Airways/American...
Here's a quick rundown from the world of business and economics this morning: the things you need to know, and some you'll just want to know.
Two tech giants continued to shine in the markets Wednesday: Hewlett-Packard and Apple. Trading was light ahead of the holiday, but the Dow and the S&P both hit new highs.
The government website created to enable Americans to buy health insurance under the Affordable Care Act will be fixed for most users by the end of November, an official says.
Boston Scientific plans to shed as many as 1,500 jobs worldwide, or 6 percent of its workforce, in an effort to cut costs.
Leading insurance company CEOs meet with top Obama administration officials to discuss solving glitches afflicting the new federal "Obamacare" insurance marketplace.
The United States spends more money on health care per capita than any other nation, and we get little in the way of longer lives or better health to show for it. Here's why.
We know: Obamacare is complicated - so complicated that a lot of people want to help you make sense of it. Here are four of the best explanations we could find.
Johnson & Johnson is recalling 200,000 bottles of Motrin Infants Drops formula due to the risk that they contain tiny particles of plastic.
AstraZeneca takes another step to bolster its pipeline of new cancer drugs by agreeing to acquire biotech company Amplimmune for up to $500 million.
About half the people who now buy their own health insurance would qualify for federal tax credits to offset rate shock, according to a new private study.
Pfizer reports better-than-expected earnings as the drugmaker lines up a business split that could lead to the spin-off of its generics division.
A handful of companies notched their own records last week, helped by the growing confidence of American consumers, but would buying these stocks now be a smart move?
Decent corporate earning had investors in a good mood Tuesday, sending the stock market higher for the fourth straight day as traders turn their attention to Q2 reports.
Walgreens will pay an $80 million fine for allowing tens of thousands of units of powerful painkillers to illegally wind up in the hands of drug addicts and dealers.
An old-fashioned model of medicine is making a comeback: You go to a doctor, get treated, and pay a reasonable fee for the services, with no health insurance company involved.